Amgen said it has filedfor an offering of two mln common shares, including one mln tobe sold outside the U.S.    It said U.S. underwriters will be led by PaineWebber GroupInc &lt;PWJ> and &lt;Montgomery Securities> and PaineWebber will leadthe overseas underwriters.    Proceeds will be used to fund capital spending and workingcapital requirements on the commercialization and furtherdevelopment of Amgen products. Reuter&#3;